American College of Clinical Pharmacy
      Search      Cart
         

Endocrine and Metabolism PRN Focus Session -- Cardiovascular Outcomes Trials in Antidiabetic Agents, and Other Clinical Pearls on All Things E&M

Sunday, October 08, 2017 from 2:15 PM to 3:45 PM MST at Phoenix Convention Center North Building Street Level: Meeting Room 126

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-17-140-L01-P
Activity Type: A Knowledge-Based Activity


Speakers
  • Christie A. Schumacher, Pharm.D., BCPS, BCACPModerator: Christie A. Schumacher, Pharm.D., BCPS, BCACP
    Associate Professor, Midwestern University Chicago College of Pharmacy, Chicago, Illinois
      View Biography

Getting to the Heart of It: An Overview of Cardiovascular Outcomes Trials in Antidiabetic Agents
2:15 PM

Speakers
  • Laura  Shane-McWhorter, Pharm.D., FASCP, BCPSSpeaker: Laura Shane-McWhorter, Pharm.D., FASCP, BCPS
    Professor, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah
      View Biography


Learning Objectives
1. Describe the rationale and historical significance behind the cardiovascular outcomes trials for antidiabetic agents.
2. Evaluate the results and implications of the cardiovascular outcomes trials and apply to clinical practice.
3. Discuss the limitations of each of the cardiovascular outcomes trials.
An Endocrinology Refresher: E&M Clinical Pearls
2:55 PM

Speakers
  • Sarah L. Anderson, Pharm.D., BCPS, BCACPSpeaker: Sarah L. Anderson, Pharm.D., BCPS, BCACP
    Associate Professor, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado
      View Biography

  • Diana Isaacs, Pharm.D., BCPSSpeaker: Diana Isaacs, Pharm.D., BCPS
    Clinical Pharmacy Specialist, Endocrinology & Metabolism Institute, Diabetes Center, Cleveland Clinic, Cleveland, Ohio

  • Brian K. Irons, Pharm.D., FCCP, BCACP, BC-ADMSpeaker: Brian K. Irons, Pharm.D., FCCP, BCACP, BC-ADM
    Professor of Pharmacy Practice, Division Head-Ambulatory Care, Texas Tech University Health Sciences Center, Lubbock, Texas
      View Biography

  • Jill S. Borchert, Pharm.D., FCCP, BCACPSpeaker: Jill S. Borchert, Pharm.D., FCCP, BCACP
    Professor and Vice Chair, Pharmacy Practice; Director, PGY2 Ambulatory Care Residency Program, Midwestern University Chicago College of Pharmacy, Chicago, Illinois
      View Biography

  • Jennifer N. Clements, Pharm.D., BCPS, CDESpeaker: Jennifer N. Clements, Pharm.D., BCPS, CDE
    Associate Professor, Department of Pharmacy Practice; Coordinator, Postgraduate Education, Presbyterian College School of Pharmacy, Clinton, South Carolina
      View Biography


Learning Objectives
1. Assess the potential advantages and disadvantages of the different therapeutic options for obesity.
2. Summarize new updates in the management of hypothyroidism.
3. Evaluate the evidence and current approaches to the management of osteoporosis.
4. Discuss the use of GLP-1 receptor agonists with basal/bolus insulin regimens.
5. Explain the role of new technology in the management of type 1 diabetes patients.